Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: City of Hope Medical Center
Condition: Multiple Myeloma and Plasma Cell Neoplasm, Neurotoxicity
NCT00792142
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.